Specify a stock or a cryptocurrency in the search bar to get a summary
Medpace Holdings Inc
MEDPMedpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio. Address: 5375 Medpace Way, Cincinnati, OH, United States, 45227
Analytics
WallStreet Target Price
355.25 USDP/E ratio
28.8906Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures MEDP
Dividend Analytics MEDP
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History MEDP
Stock Valuation MEDP
Financials MEDP
Results | 2019 | Dynamics |